Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Type 2 Diabetes Mellitus
Condition: Initial treatment
Dose: Tablet – 2.5 mg/250 mg (glipizide/metformin)
Frequency: once daily
Note: Take by mouth with food. May adjust daily dose in increments of 1 tablet every 2 weeks. Maximum: Glipizide 10 mg and metformin 2,000 mg daily. Hepatic impairment: Contraindicated.
Indication: Type 2 Diabetes Mellitus
Condition: Initial treatment with fasting plasma glucose = 280-320 mg/dL
Dose: Tablet – 2.5 mg/500 mg (glipizide/metformin)
Frequency: every 12 hours
Note: Take by mouth. May adjust daily dose in increments of 1 tablet every 2 weeks. Maximum: Glipizide 10 mg and metformin 2,000 mg daily. Hepatic impairment: Contraindicated.

Child Dose

Clinical InformationAdministration Information
Age: Child
Dose: Not applicable – No approved dosage
Note: No approved pediatric dosage available

Renal Dose

Clinical InformationAdministration Information
Condition: Estimated glomerular filtration rate less than 30 mL/minute/1.73 m²
Dose: Metformin – Not applicable
Note: Contraindicated; If estimated glomerular filtration rate falls below 30 mL/minute/1.73 m² while taking metformin, discontinue the drug
Condition: Estimated glomerular filtration rate 30-45 mL/minute/1.73 m²
Dose: Metformin – Not recommended to initiate treatment
Note: If estimated glomerular filtration rate falls below 45 mL/minute/1.73 m² while taking metformin, risks and benefits of continuing therapy should be evaluated
Administration
  • Take with meals
  • Regular timing
Side Effect

Drug Interaction

Drug NameRisk Factors
Beta-blockers (Propranolol, Metoprolol, Atenolol, Bisoprolol, Carvedilol, Nadolol, Timolol, Sotalol), Cholestyramine, Hydantoins, Thiazide diuretics (Chlorothiazide, Chlorthalidone, Hydrochlorothiazide, Indapamide, Metolazone), Urinary alkalinizers
Decreased effect (Glipizide)
Fluconazole, Gemfibrozil, Ketoconazole, NSAIDs (Ibuprofen, Naproxen, Diclofenac, Celecoxib, Meloxicam, Indomethacin, Piroxicam, Ketorolac), Pioglitazone, Sulfonamides
Increased glipizide levels and effects (Glipizide)

Disease Interaction

Disease NameRisk Factors
Type 2 Diabetes Mellitus, Ketoacidosis
Can worsen metabolic complications
Severe Renal and Hepatic Insufficiency
Can cause drug accumulation

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store below 25ºC in a cool and dry place.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.